CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
AirWazedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06046001
NCT06046001N/ACompleted
CompareCT.gov

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions

Philips Clinical & Medical Affairs Global·interventional·Posted Sep 21, 2023·Updated Apr 16, 2026

In Brief

A clinical study evaluating AirWaze for Lung Diseases. Completed, enrolled 37 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to assess the overall usability of the Philips AirWaze investigational device in patients indicated for CBCT-guided navigation bronchoscopy procedure. The main questions it aims to answer are to assess the: * overall usability of the device * accuracy of the tool-in-lesion confirmation scan Participants will undergo bronchoscopy with the new navigation device and additional confirmation scans. Follow-up visit at 7days will be performed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedSep 21, 2023
Enrollment StartOct 27, 2023
Primary CompletionDec 20, 2024
Study CompletionJan 3, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.8 years ago

Interventions

AirWazedevice

AirWaze - easy and advanced tools for CBCT guided lung interventions